Virtus ETF Advisers’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-25,259
| Closed | -$612K | – | 181 |
|
|
2017
Q1 | $612K | Buy |
25,259
+2,429
| +11% | +$58.9K | 0.11% | 92 |
|
|
2016
Q4 | $733K | Buy |
22,830
+10,109
| +79% | +$325K | 0.22% | 84 |
|
|
2016
Q3 | $636K | Buy |
12,721
+1,603
| +14% | +$80.1K | 0.31% | 60 |
|
|
2016
Q2 | $472K | Buy |
11,118
+7,105
| +177% | +$302K | 0.35% | 63 |
|
|
2016
Q1 | $264K | Sell |
4,013
-254
| -6% | -$16.7K | 0.36% | 62 |
|
|
2015
Q4 | $265K | Buy |
+4,267
| New | +$265K | 0.73% | 54 |
|